论文部分内容阅读
目的分析舒血宁加氯吡格雷治疗脑梗死临床治疗效果。方法选取2013年1月~2016年1月我院收治的脑梗死后12~48h的135例患者病历,对其进行详细地回顾与分析,将其随机分为治疗组(65例)和对照组(70例),两组患者均给予控制血糖和血压等基础治疗,治疗组给予舒血宁联合氯吡格雷药物治疗,对照组在基础治疗上实施舒血宁治疗,以15天为治疗疗程,分别观察两组患者临床治疗总有效率和神经缺损评分。结果与结论对于脑梗死12~48h患者给予舒血宁联合氯吡格雷药物治疗效果显著,值得临床推广应用。
Objective To analyze the clinical effect of Shuxuening plus clopidogrel in the treatment of cerebral infarction. Methods From January 2013 to January 2016 in our hospital from 12 to 48h after admission of cerebral infarction in 135 cases of patients were reviewed and analyzed in detail, were randomly divided into treatment group (65 cases) and control group (70 cases). Both groups were given basic treatment such as blood sugar control and blood pressure. The treatment group was treated with Shuxuening plus clopidogrel drug. The control group was treated with Shuxuening on the basis of treatment. The treatment course was 15 days. Clinical efficacy and neurological deficit score were observed in two groups. RESULTS AND CONCLUSIONS The effect of Shuxuening combined with Clopidogrel was significant in patients with cerebral infarction between 12 and 48 hours, which is worthy of clinical application.